Table 1.
Patient and tumor characteristics at baseline.
| Characteristics | Patients, N = 65 (%) |
|---|---|
| Sex | |
| Male | 54 (83.1) |
| Median age, years (range) | 60.5 (40.6–76.7) |
| WHO Performance Status | |
| 0 | 41 (63.1) |
| 1 | 23 (35.4) |
| 2 | 1 (1.5) |
| Malnutrition | 11 (16.9) |
| Primary tumor location | |
| Junctional cancer | 45 (69.2) |
| Siewert type I | 22 (48.9) |
| Siewert type II | 20 (44.4) |
| Siewert type III | 3 (6.7) |
| Gastric cancer | 20 (30.8) |
| Fundus | 3 (15.0) |
| Body | 6 (30.0) |
| Pyloric antrum | 11 (55.0) |
| Echoendoscopy done | 62 (95.4) |
| traversable tumor | 49 (79.0) |
| usT stage | |
| usT1 | 1/49 (2.0) |
| usT2 | 7/49 (14.3) |
| usT3 | 40/49 (81.6) |
| usT4 | 1/49 (2.0) |
| usN stage | |
| usN0 | 8/49 (16.3) |
| usN1 | 41/49 (83.7) |
| Clinical tumor stage at inclusion | |
| II | 14/49 (28.6) |
| III | 35/49 (71.4) |
| Poorly cohesive cells on biopsies | l0/61 (16.4) |
WHO: World Health Organization; Malnutrition: Weight loss > 10% in 3 months, Siewert classification [15].